Harrow (HROW.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov11

William Blair Maintains Buy Rating on HROW: Strong Product Performance and Effective Cost Management

07:46

Harrow released FY2025 Q3 earnings on November 10 After-Market EST, actual revenue USD 71.64 M (forecast USD 73.7 M), actual EPS USD 0.03 (forecast USD 0.2614)

00:00

Harrow released FY2025 9 Months earnings on November 10 After-Market EST, actual revenue USD 183.21 M, actual EPS USD -0.3388

00:00

Nov3

Harrow to Release FY2025 Q3 Earnings on November 10 After-Market EST, Forecast Revenue USD 73.7 M, EPS USD 0.2614

00:16

Oct24

Analyst Knickerbocker Gives Harrow Health Strong Buy Rating

14:07

Oct13

Analyst Reiterates Hold Rating on Harrow Health Stock

13:21

Schedules & Filings

Schedules

Filings

Nov10

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 71.64 M, Net Income 1.02 M, EPS 0.0274

Aug11

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 63.74 M, Net Income 4.995 M, EPS 0.1299

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 47.83 M, Net Income -17.78 M, EPS -0.4962

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More